Form D · Other Health Care
GenoTwin, Inc.
Bridgewater, MA · CIK 0001836624
Offering snapshot reported Dec 15, 2020 · SEC filing
- Reported sold
- $200K Offering amount: $1.2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2020 | Initial | $200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-383283
Source: Form D, filed Dec 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Reuben Danzing | Executive |
| Oliver Elliott | Director, Executive |
| Seunghee Ham | Director |
| Raul Rabadan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
38 Clarence Avenue
Bridgewater, MA, 02324
Bridgewater, MA, 02324